2,054
Views
12
CrossRef citations to date
0
Altmetric
Articles

Low-dosage antibiotic intake can disturb gut microbiota in mice

La ingesta de bajas dosis de antibióticos es capaz de alterar la microbiota intestinal en ratones

, , , ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 672-678 | Received 17 Jan 2018, Accepted 01 May 2018, Published online: 18 Jun 2018

References

  • Abdou, R. M., Zhu, L., Baker, R. D., & Baker, S. S. (2016). Gut microbiota of nonalcoholic fatty liver disease. Digestive Diseases and Sciences, 61, 1268–1281.
  • Andersson, D. I., & Hughes, D. (2014). Microbiology effects of sublethal levels of antibiotics. Nature Reviews. Microbiology, 12, 465–478.
  • Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., … Bork, P. (2011). Enterotypes of the human gut microbiome. Nature, 473, 174–180.
  • Azad, M. B., Bridgman, S. L., Becker, A. B., & Kozyrsky, A. L. (2014). Infant antibiotic exposure and the development of childhood overweight and central adiposity. International. Journal of Obesity, 38, 1290–1298.
  • Caporaso, J. G., Lauber, C. L., Costello, E. K., Berg-Lyons, D., Gonzalez, A., Stombaugh, J., … Knight, R. (2011). Moving pictures of the human microbiome. Genome Biology, 12, R50.
  • Castro-Penalonga, M., Roca-Saavedra, P., Miranda, J. M., Porto-Arias, J. J., Nebot, C., Cardelle-Cobas, A., … Cepeda, A. (2018). Influence of food consumption patterns and galician lifestyle on human gut microbiota. Journal of Physiology and Biochemistry, 74, 85–92.
  • Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadi, J., Li, K., … Blaser, M. J. (2012). Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature, 488, 621–626.
  • Clemente, J. C., Pehrsson, E. C., Blaser, M. J., Sandhu, K., Gao, Z., Wang, B., … Dominguez-Bello, M. G. (2015). The microbiome of uncontacted Amerindians. Science Advances, 1, e1500183.
  • Conlon, M. A., & Bird, A. R. (2015). The impact of diet and lifestyle on gut microbiota and human health. Nutrients, 7, 17–44.
  • Cox, L. M., & Blaser, M. J. (2015). Antibiotics in early life and obesity. Nature Reviews of Endocrinology, 11, 182–190.
  • Ellekilde, M., Selfjord, E., Larsen, C. S., Jakesevic, M., Rine, I., Tranberg, B., … Nielsen, D. S. (2014). Transfer of gut microbiota from lean and obese mice to antibiotic-treated mice. Scientific Reports, 4, 5922.
  • European Union (EU). (2003). Regulation (EC) No 1831/2003 of the European Parliament and the Council of 22 September 2003, on additives for use in animal nutrition. Official Journal of the European Union, L268, 29–43.
  • European Union (EU). (2010a). Regulation 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. Official Journal of the European Union, L15, 1–72.
  • European Union (EU). (2010b). Directive 2010/63/EU of the European Parliament and of the Council of 22 september 2010 on the protection of animals used for scientific purposes. Official Journal of the European Union, L273, 33–79.
  • Fröhlich, E. E., Farzi, A., Mayerhofer, R., Reichmann, F., Jacan, A., Wagner, B., … Holzer, P. (2016). Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication. Brain, Behavior and Immunity, 56, 140–155.
  • Georgieva, R., Yocheva, L., Tserovska, L., Zhelezova, G., Stefanova, N., Atanasova, A., … Karaivanova, E. (2015). Antimicrobial activity and antibiotic susceptibility of Lactobacillus and Bifidobacterium spp. intended for use as starter and probiotic cultures. Biotechnology and Biotechnological Equipment, 29, 84–91.
  • Grave, K., Torren-Edo, J., Muller, A., Greko, C., Moulin, G., & Mackay, D. (2014). Variations in the sales and sales patterns of veterinary antimicrobial agents in 24 European countries. Journal of Antimicrobial Chemotheraphy, 69, 284–2291.
  • Guarddon, M., Miranda, J. M., Rodriguez, J. A., Vázquez, B. I., Cepeda, A., & Franco, C. M. (2011). Real-time polymerase chain reaction for the quantitative detection of tetA and tetB bacterial tetracycline resistant genes in food. International Journal of Food Microbiology, 146, 284–289.
  • Gueimonde, M., Sánchez, B., de Los Reyes-Gavilán, C. G., & Margolles, A. (2013). Antibiotic resistance in probiotic bacteria. Frontiers in Microbiology, 4, 202.
  • Hu, Y., Yang, X., Qin, J., Lu, N., Cheng, G., Wu, N., … Zhu, B. (2013). Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nature Communications, 4, 2151.
  • Korpela, K., & de Vos, W. M. (2016). Antibiotic use in childhood alters the gut microbiota and predisposes to overweight. Microbial Cell, 7, 296–298.
  • Leclercq, S., Mian, F. M., Stanisz, A. M., Bindels, L. B., Cambier, E., Ben-Amaram, H., … Bienestock, J. (2017). Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. Nature Communications, 8, 15062.
  • Mikkelsen, K. H., Allin, K. H., & Knop, F. K. (2016). Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: A review of the literature. Diabetes, Obesity and Metabolism, 18, 444–453.
  • Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., … Huttenhower, C. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biology, 13, R79.
  • Moubareck, C., Gavini, F., Vaugien, L., Butel, M. J., & Doucet-Populaire, F. (2005). Antimicrobial susceptibility of bifidobacteria. Journal of Antimicrobial Chemotherapy, 55, 38–44.
  • Murphy, E. F., Clarke, S. F., Marques, T. M., Hill, C., Stanton, C., Roos, P., & Cotter, P. D. (2013). Strategies for targeting obesity and metabolic health? Gut Microbes, 4, 48–51.
  • Murri, M., Leiva, I., Gomez-Zumaquero, J. M., Tinahones, F. J., Cardona, F., & Queipo-Ortuño, M. J. (2013). Gut microbiota in children with type I diabetes differs from that in healthy children: A case-control study. BMC Medicine, 11, 46–57.
  • Nguyen, T. L. A., Vieira-Silva, S., Liston, A., & Raes, J. (2015). How informative if the mmouse for human gut microbiota research? Disease Models & Mechanisms, 8, 1–16.
  • Nobel, Y. R., Cox, L. M., Kirigin, F. F., Bokulich, N. A., Yamanishi, S., Teitler, I., … Blaser, M. J. (2015). Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nature Communications, 6, 7486.
  • Okubo, H., Sakoda, H., Kushiyama, A., Fujishiro, M., Nakatsu, Y., & Asano, T. (2013). Lactobacillis casei strain Shirota protects against nonalcoholic steatohepatitis developments in a rodent model. American Journal of Physiology Gastrointestinal and Liver Physiology, 305, G911–G918.
  • Panda, S., El Khader, I., Casellas, F., Lopez Vivancos, J., García Cors, M., & Manichanh, C. (2014). Short-term effect of antibiotics on human gut microbiota. PLoS One, 9, e95476.
  • Power, S. E., O´Toole, P. W., Stanton, C., Ross, R. P., & Fitzgerald, G. F. (2014). Intestinal microbiota, diet and health. British Journal of Nutrition, 111, 387–402.
  • Riley, L. W., Raphael, E., & Faerstein, E. (2013). Obesity in the United States- dysbiosis from exposure to low-dosage antibiotics? Frontiers in Public Health, 69, 1–8.
  • Roca-Saavedra, P., Mendez-Vilabrille, V., Miranda, J. M., Nebot, C., Cardelle-Cobas, A., Franco, C. M., & Cepeda, A. (2018). Food additives, contaminants and other minor components: Effects on human gut microbiota-a review. Journal of Physiology and Biochemistry, 74, 69–83.
  • Rodriguez-Costa, S., Cardelle-Cobas, A., Roca-Saavedra, P., Porto-Arias, J. J., Miranda, J. M., & Cepeda, A. (2018). In vitro evaluation of the probiotic effect of red and white grape polyphenolic extracts. Journal of Physiology and Biochemistry, 74, 101–110.
  • Russell, S. L., Gold, M. J., Reynolds, L. A., Willing, B. P., Dimitriu, P., & McNagny, K. M. (2015). Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases. Journal of Allergy and Clinical Inmunology, 135, 100–109.
  • Singh, V., Yeon, B. S., & Vijay-Kumar, M. (2016). Gut microbiome as a novel cardiovascular therapeutic target. Current Opinion in Pharmacology, 27, 8–12.
  • Temmerman, R., Pot, B., Huys, G., & Swings, J. (2003). Identification and antibiotic susceptibility of bacterial isolates from probiotic products. International Journal of Food Microbiology, 81, 1–10.
  • Ternak, G. (2005). Antibiotics may act as growth/obesity promoters in humans as an inadvertent result of antibiotic pollution? Medical Hypotheses, 64, 14–16.
  • Thuny, F., Richet, H., Casalta, J. P., Angelakis, E., Habib, G., & Raoult, D. (2010). Vancomycin treatment of infective andocarditis is linked with recently acquired obesity. PLoS One, 5, e9074.
  • Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009). The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Science Translational Medicine, 1, 6ra14.
  • Vrieze, A., Out, C., Fuentes, S., Jonker, L., Reuling, I., & Nieuwdorp, M. (2014). Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. Journal of Hepatology, 60, 824–831.